A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 611 shares of NVS stock, worth $67,527. This represents 0.02% of its overall portfolio holdings.

Number of Shares
611
Previous 587 4.09%
Holding current value
$67,527
Previous $62,000 12.9%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$106.13 - $120.89 $2,547 - $2,901
24 Added 4.09%
611 $70,000
Q2 2024

Jul 05, 2024

BUY
$92.57 - $107.37 $54,338 - $63,026
587 New
587 $62,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Thurston, Springer, Miller, Herd & Titak, Inc. Portfolio

Follow Thurston, Springer, Miller, Herd & Titak, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thurston, Springer, Miller, Herd & Titak, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Thurston, Springer, Miller, Herd & Titak, Inc. with notifications on news.